Regeneron’s star bispecific is linked to 2 deaths in a small study — which was no help for its Q1 call

Regeneron’s star bispecific is linked to 2 deaths in a small study — which was no help for its Q1 call

Source: 
Endpoints
snippet: 

Regeneron execs chose to disclose in their Q1 call with analysts today that their closely watched bispecific REGN1979 was linked with two deaths from cytokine release syndrome in a small study involving 30 patients.